Animal research shows that gymnema, administered orally for 7 days, increases the clearance of tolbutamide by 2.4-fold when compared to control
Not long ago, if someone mentioned a GLP-1 medication, the conversation almost always centered on weight loss
In a large Phase 3 clinical trial (STEP series), semaglutide demonstrated excellent weight loss and weight maintenance after weight loss
Additionally, sequential use of the medications, starting with GLP-1 receptor agonists, appears to lead to more significant weight loss
However, when people stop taking these drugs, most will regain about two-thirds of the weight they lost within a year
GLP-1 drugs for heart health Trulicity (dulaglutide) was approved in 2020 for individuals with type 2 diabetes, with or without a history of heart disease, to help reduce the risk of serious cardiovascular events, like heart attacks